Elsayed N, Wolfe A, Burk R
Front Cell Infect Microbiol. 2024; 13:1308665.
PMID: 38274734
PMC: 10808152.
DOI: 10.3389/fcimb.2023.1308665.
Nagata M, Tome A, White K, Wilkens L, Park S, Le Marchand L
Cancers (Basel). 2023; 15(21).
PMID: 37958367
PMC: 10648031.
DOI: 10.3390/cancers15215194.
Adus-Salam A, Jimoh M, Ehiedu C
Ecancermedicalscience. 2023; 17:1577.
PMID: 37533949
PMC: 10393305.
DOI: 10.3332/ecancer.2023.1577.
Laurence M, Asquith M, Rosenbaum J
Front Med (Lausanne). 2018; 5:80.
PMID: 29675414
PMC: 5895656.
DOI: 10.3389/fmed.2018.00080.
Cirakoglu A, Benli E, Yuce A
Int Braz J Urol. 2018; 44(4):704-708.
PMID: 29570262
PMC: 6092644.
DOI: 10.1590/S1677-5538.IBJU.2017.0525.
The Role of Fungi in the Etiology of Multiple Sclerosis.
Benito-Leon J, Laurence M
Front Neurol. 2017; 8:535.
PMID: 29085329
PMC: 5650687.
DOI: 10.3389/fneur.2017.00535.
A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer.
Chang E, Boffetta P, Adami H, Cole P, Mandel J
Eur J Epidemiol. 2014; 29(10):667-723.
PMID: 25064616
PMC: 4197347.
DOI: 10.1007/s10654-014-9931-2.
MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.
Sutcliffe S, De Marzo A, Sfanos K, Laurence M
Prostate. 2014; 74(6):569-78.
PMID: 24464504
PMC: 4037912.
DOI: 10.1002/pros.22778.
The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer.
Elkahwaji J
Res Rep Urol. 2014; 5:1-10.
PMID: 24400229
PMC: 3826944.
DOI: 10.2147/RRU.S23386.
A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago.
McDonald A, Jenkins F, Bunker C, Wilson J, Patrick A, Weissfeld J
Infect Agent Cancer. 2011; 6:25.
PMID: 22151996
PMC: 3248833.
DOI: 10.1186/1750-9378-6-25.
Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis.
Lin Y, Mao Q, Zheng X, Yang K, Chen H, Zhou C
Ir J Med Sci. 2011; 180(2):497-503.
PMID: 21400096
DOI: 10.1007/s11845-011-0692-6.
Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients.
Chen A, Waterboer T, Keleher A, Morrison B, Jindal S, McMillan D
Pathol Oncol Res. 2011; 17(3):613-7.
PMID: 21240663
DOI: 10.1007/s12253-010-9357-4.
Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
Sutcliffe S, Viscidi R, Till C, Goodman P, Hoque A, Hsing A
Cancer Epidemiol Biomarkers Prev. 2010; 19(2):614-8.
PMID: 20142255
PMC: 2820385.
DOI: 10.1158/1055-9965.EPI-09-1080.
Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate.
Elkahwaji J, Hauke R, Brawner C
Br J Cancer. 2009; 101(10):1740-8.
PMID: 19844236
PMC: 2778530.
DOI: 10.1038/sj.bjc.6605370.
Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy.
Ellem S, Wang H, Poutanen M, Risbridger G
Am J Pathol. 2009; 175(3):1187-99.
PMID: 19700748
PMC: 2731137.
DOI: 10.2353/ajpath.2009.081107.
Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach.
Caruso C, Balistreri C, Candore G, Carruba G, Colonna-Romano G, Di Bona D
Cancer Immunol Immunother. 2009; 58(12):1919-33.
PMID: 19221747
PMC: 11030552.
DOI: 10.1007/s00262-009-0658-y.
Sexually transmissible infections and prostate cancer risk.
Huang W, Hayes R, Pfeiffer R, Viscidi R, Lee F, Wang Y
Cancer Epidemiol Biomarkers Prev. 2008; 17(9):2374-81.
PMID: 18768506
PMC: 2559953.
DOI: 10.1158/1055-9965.EPI-08-0173.
Inflammation and prostate cancer: a focus on infections.
Sutcliffe S, Platz E
Curr Urol Rep. 2008; 9(3):243-9.
PMID: 18765120
DOI: 10.1007/s11934-008-0042-z.
Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Sutcliffe S, Giovannucci E, Gaydos C, Viscidi R, Jenkins F, Zenilman J
Cancer Epidemiol Biomarkers Prev. 2007; 16(8):1573-80.
PMID: 17684131
PMC: 3012386.
DOI: 10.1158/1055-9965.EPI-07-0134.
Inflammation in prostate carcinogenesis.
De Marzo A, Platz E, Sutcliffe S, Xu J, Gronberg H, Drake C
Nat Rev Cancer. 2007; 7(4):256-69.
PMID: 17384581
PMC: 3552388.
DOI: 10.1038/nrc2090.
